skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi Peter,

Given what's going on with lawsuits and other pressures at GXI:

http://business.financialpost.com/news/fp-street/will-defamation-suit-proxy-battle

What's your take on all of this noise?
Read Answer Asked by Sheldon on May 10, 2015
Q: Can I get your updated views on Lumenpulse? Previous comments seem to suggest you are warming up to it, but the stock hasn't done much in the past 6 months. What would be a catalyst to provide some positive stock momentum?

Thanks!
Read Answer Asked by Mike on May 10, 2015
Q: Hi Peter and team,
As a small cap,is its growth sustainable? Or it may be a potential target of acquisition?
Thanks!
Jim
Read Answer Asked by Jim on May 06, 2015
Q: Hi Team

I was wondering what you know about HRX, seems like it has good rating from Scotia bank. Is it a buy at this price . and what can you tell me about it
Read Answer Asked by glenn on April 24, 2015
Q: Good Evening, I would like to ask about Guestlogix. I am curious about them because of what they offer in the airline industry. When you think about it, when one goes to the airport they almost always have to purchase something, such as food, because it is more of a hassle trying to get it through the gate. Anyways, would appreciate your input on this company.
Seamus
Read Answer Asked by Seamus on April 24, 2015
Q: PLEASE advise as to your opinion on the growth of this co.
thank you JACK
Read Answer Asked by Jack on April 03, 2015
Q: I have had a nice pop on this stock(FTG Firan).Can you give me some advise going forward.Thanks
Read Answer Asked by Don on March 31, 2015
Q: I wonder if you can comment on the latest earnings report from Savaria. It would seem to warrant a more positive share price reaction.
Read Answer Asked by robert on March 30, 2015
Q: After experiencing healthy gains in Patient Home Monitoring, I read through the entire Convalo Health website to learn about their company. Their plans has some good potential but seems to rely heavily on new insurance-paid therapies. If the Republicans win the next election and skewer Obama's healthcare plan, will this significantly affect Convalo's business model? Second, they presently have one location where they have increased sales from $80K to $300K and around $5M in cash. I assume they will have to do a "healthy" raise to grow similar to PHM.
Your analysis would be appreciated.
Thanks.
Read Answer Asked by Steven on March 30, 2015
Q: The last question on DDC was Nov 13/13, at which time you called it an OK - type of company. It appears since then to have changed for the better. Certainly it is doing better than most of its peers. Thru my bank acct I have access to Value Engine analysis of DDC. According to them DDC's fair market value is $37. So I'm thinking this may be a good buy. I'm not sure how to interpret their balance sheet, however There is no line that says "debt" - just a comparison of Assets to Liabilities; which to my untrained eyes looks pretty good(assets=3x liabilities).So what are the debt issues, if any with this company? Are there any other red flags I should be aware of? Lastly, how do view DDC today.
Thankyou----I really enjoy your service.
Read Answer Asked by Lionel on March 30, 2015
Q: I'm up over 300%. It was a very conservative buy in the first place, so even with gain, it is a reasonable position in my portfolio. I read a report this weekend that they may not be completely forthcoming with their income statement, that Net Operating Profit in Q1 2015 was listed as $1.572 million, but the fine print indicated that this figure excluded the amortization of intangible assets, stock-based compensation, the gain or loss on derivative financial liability, interest expense, and income tax expense. With the inclusion of these expenses, Q1 would present quite differently. Is this an ethical presentation, and should I be concerned with holding this stock? How does the balance sheet look? Because of my small position, I had planned on holding for a couple of years and riding out the volatility, but of course it's a shame to lose the gain if they are not presenting the true picture, and the stock is weaker than it appears. Your opinion please. Thank-you.
Read Answer Asked by Kim on March 30, 2015
Q: What do you make of their latest financial report? Would you buy this stock now? Thank you.
Read Answer Asked by John on March 30, 2015
Q: I know you like Knight Therapeutics. Stock has been hit quite hard recently, and currently is trading around $8. Do you think it's a good entry price here? Also is it a safe stock to hold in a RESP account? (My kids are quite young, so the money inside RESP won't be cashed for minimum 10 years.)Thanks for your great advice!
Read Answer Asked by Rebecca on March 26, 2015
Q: Hello, could we have your thoughts on the current valuation and prospects for Savaria. It is approaching 6 per cent of my portfolio which is pretty high for a company of this size I think. Thanks.
Read Answer Asked by Adam on March 24, 2015
Q: Mr. Dalsin has said in three different calls/interviews now that a dividend, by the company, is one of their milestones once they reach the 20-25 million EBITDA. Do you still consider the initiation of a dividend as being one of the strongest indicators of a company's strength?
Read Answer Asked by Kyle on March 23, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!